Minalrestat structure, CAS 129688-50-2

Minalrestat

CAS Number129688-50-2

SynonymsMinalrestat (USAN/INN); Minalrestat; WAY-ARI-509; Bffipt

Molecular FormulaC19H11BrF2N2O4

Molecular Weight449.21

Purity98.00%

Density1.79g/cm3

Boiling Point707.4ºC at 760mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9011454 Purity: 98.00%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 129688-50-2 ] Purity: 98.00% SDS Specification MoL

Chemical & Physical Properties
CAS Number129688-50-2
Catalog No.2A-9011454
Chinese Name米那司他
SynonymsMinalrestat (USAN/INN); Minalrestat; WAY-ARI-509; Bffipt
Molecular FormulaC19H11BrF2N2O4
Molecular Weight449.21
Purity98.00
Density1.79g/cm3
Boiling Point707.4ºC at 760mmHg
ApplicationMinasstat (ARI-509) is a potent orally active aldose reductase inhibitor. Minasstat can be used in diabetes research [1].
HTC2933990090
MDL NumberC19H11BrF2N2O4
SMILESO=C1CC2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1ccc(F)cc12
InChIInChI=1S/C19H11BrF2N2O4/c20-10-2-1-9(14(22)5-10)8-24-16(26)12-4-3-11(21)6-13(12)19(18(24)28)7-15(25)23-17(19)27/h1-6H,7-8H2,(H,23,25,27)
InChI KeyBMHZAHGTGIZZCT-UHFFFAOYSA-N
MSDSmsds/11454_1_129688_50_2.pdf
Use ofMinalrestat (ARI-509) is a potent and orally active aldose reductase inhibitor. Minalrestat can be used in the research of diabetes[1]. Properties Name 2-[(4-bromo-2-fluorophenyl)methyl]-6-fluorospiro[isoquinoline-4,3'-pyrrolidine]-1,2',3,5'-tetrone Synonym More Synonyms Minalrestat Biological Activity Description Minalrestat (ARI-509) is a potent and orally active aldose reductase inhibitor. Minalrestat can be used in the research of diabetes[1]. Related Catalog Signaling Pathways >> Metabolic Enzyme/Protease >> Aldose Reductase Research Areas >> Metabolic Disease In Vitro Minalrestat (100 μM) Reduces sorbitol content in primary cultured rat cells without affecting intracellular glucose content [3]. Minalrestat (100 μM, 48 h) causes the accumulation of PKC-α and -β2 in primary cultured rat mesangial cells [3]. Western Blot Analysis[3] Cell Line: Primary cultured rat mesangial cells Concentration: 100 μM Incubation Time: 48 h Result: Increased accumulation of PKC-α and -β2. References [1]. Akamine EH, et al. Minalrestat, an aldose reductase inhibitor, corrects the impaired microvascular reactivity in diabetes. J Pharmacol Exp Ther. 2003 Mar;304(3):1236-42. [2]. Cruz JW, et al. Minalrestat and leukocyte migration in diabetes mellitus. Diabetes Metab Res Rev. 2003 May-Jun;19(3):223-31. [3]. Kapor-Drezgic J, et al. Effect of high glucose on mesangial cell protein kinase C-delta and -epsilon is polyol pathway-dependent. J Am Soc Nephrol. 1999 Jun;10(6):1193-203. Chemical & Physical Properties Molecular Formula C19H11BrF2N2O4 Exact Mass 447.98700 PSA 83.55000 LogP 2.46090 Index of Refraction 1.689 InChIKey BMHZAHGTGIZZCT-UHFFFAOYSA-N Safety Information HS Code 2933990090
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Related Products in Specialty Chemicals
Milfasartan148564-47-02A-9011448
Milnacipran92623-85-32A-9011449
Milodistim137463-76-42A-9011450
Milrinone78415-72-22A-0200652
Milverine75437-14-82A-9011453
Minaprin dihydrochloride25905-77-52A-9011455
Mindodilol70260-53-62A-9011456
Minodronic acid127657-42-52A-9011458
Minoxidil38304-91-52A-9011459
Minoxidil sulfate83701-22-82A-0200856
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA